Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Erlotinib | 0.31623 | uM | 9 | 2500.00 | 1861.36 | 3738.00 | 3836.75 | 0.9743 | 0.9506 |
| SK-BR-3 | 0 | uM | 9 | 2500.00 | 1861.36 | 3912.00 | 3836.75 | 1.0196 | 1.0376 | |
| SK-BR-3 | Linsitinib | 19.9526 | uM | 9 | 2500.00 | 1861.36 | 2539.00 | 3836.75 | 0.6618 | 0.3465 |
| SK-BR-3 | Linsitinib | 0.0033113 | uM | 9 | 2500.00 | 1861.36 | 3899.00 | 3836.75 | 1.0162 | 1.0311 |
| SK-BR-3 | Erlotinib | 10 | uM | 9 | 2500.00 | 1861.36 | 1935.00 | 3836.75 | 0.5043 | 0.0379 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 9 | 2500.00 | 1861.36 | 3166.00 | 3836.75 | 0.8252 | 0.6636 |
| SK-BR-3 | 17-AAG | 0.0031623 | uM | 9 | 2500.00 | 1861.36 | 3702.00 | 3836.75 | 0.9649 | 0.9326 |
| SK-BR-3 | Erlotinib | 0.01 | uM | 9 | 2500.00 | 1861.36 | 4169.00 | 3836.75 | 1.0866 | 1.1657 |
| SK-BR-3 | Linsitinib | 0.01 | uM | 9 | 2500.00 | 1861.36 | 4057.00 | 3836.75 | 1.0574 | 1.1099 |
| SK-BR-3 | 17-AAG | 0.0001 | uM | 9 | 2500.00 | 1861.36 | 4060.00 | 3836.75 | 1.0582 | 1.1114 |
| SK-BR-3 | 17-AAG | 0.01 | uM | 9 | 2500.00 | 1861.36 | 2720.00 | 3836.75 | 0.7089 | 0.4384 |
| SK-BR-3 | Linsitinib | 10 | uM | 9 | 2500.00 | 1861.36 | 3171.00 | 3836.75 | 0.8265 | 0.6662 |
| SK-BR-3 | 0 | uM | 9 | 2500.00 | 1861.36 | 4188.00 | 3836.75 | 1.0915 | 1.1751 | |
| SK-BR-3 | Lapatinib | 1 | uM | 9 | 2500.00 | 1861.36 | 1581.00 | 3836.75 | 0.4121 | -0.1448 |
| SK-BR-3 | Lapatinib | 10 | uM | 9 | 2500.00 | 1861.36 | 1287.00 | 3836.75 | 0.3354 | -0.2979 |
| SK-BR-3 | Lapatinib | 0.0033113 | uM | 9 | 2500.00 | 1861.36 | 3268.00 | 3836.75 | 0.8518 | 0.7150 |
| SK-BR-3 | Linsitinib | 0.1 | uM | 9 | 2500.00 | 1861.36 | 3827.00 | 3836.75 | 0.9975 | 0.9951 |
| SK-BR-3 | Lapatinib | 0.031623 | uM | 9 | 2500.00 | 1861.36 | 2390.00 | 3836.75 | 0.6229 | 0.2707 |
| SK-BR-3 | 17-AAG | 0.031623 | uM | 9 | 2500.00 | 1861.36 | 2048.00 | 3836.75 | 0.5338 | 0.0959 |
| SK-BR-3 | 0 | uM | 9 | 2500.00 | 1861.36 | 3786.00 | 3836.75 | 0.9868 | 0.9746 | |
| SK-BR-3 | 0 | uM | 9 | 5000.00 | 3570.27 | 5793.00 | 5810.50 | 0.9970 | 0.9914 | |
| SK-BR-3 | 0 | uM | 9 | 5000.00 | 3570.27 | 5667.00 | 5810.50 | 0.9753 | 0.9301 | |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 9 | 5000.00 | 3570.27 | 5600.00 | 5810.50 | 0.9638 | 0.8977 |
| SK-BR-3 | 17-AAG | 0.001 | uM | 9 | 5000.00 | 3570.27 | 5510.00 | 5810.50 | 0.9483 | 0.8544 |
| SK-BR-3 | 17-AAG | 0.000066069 | uM | 9 | 5000.00 | 3570.27 | 5627.00 | 5810.50 | 0.9684 | 0.9107 |